Home NDC 24201-150 Medroxyprogesterone Acetate Injectable Suspension
Product NDC 24201-150
11-digit product format 242010150
Labeler code 24201
Product ID 24201-150_3bf1d302-025e-447c-8480-065dd9f01849
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name medroxyprogesterone acetate
Dosage form INJECTION, SUSPENSION
Route INTRAMUSCULAR
Labeler Hikma Pharmaceuticals USA Inc.
Application ANDA214309
Marketing category ANDA
Marketing start 2023-05-01
Substance MEDROXYPROGESTERONE ACETATE
Active strength 150 mg/mL
Pharmacologic classes Progesterone Congeners [CS], Progestin [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A214309-001 MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2023-01-05 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2023-01-05 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2023-01-05 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2023-01-05 3bdfa0b2c4d7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A214309-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION 2023-01-05 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A214309-001 AB 1 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A214309-001 AB 1 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A214309-001 AB 1 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A214309-001 AB 1 3bdfa0b2c4d7…
Additional Listing Data#
Finished product Yes
Brand name base Medroxyprogesterone Acetate Injectable Suspension
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MEDROXYPROGESTERONE ACETATE 150 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination C2QI4IOI2G Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1000126 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 24201-150-00 Medroxyprogesterone Acetate Injectable Suspension 1 mL in 1 VIAL INJECTION, SUSPENSION 1 3 24201-150-01 Medroxyprogesterone Acetate Injectable Suspension 1 in 1 CARTON INJECTION, SUSPENSION 1 3 24201-150-25 Medroxyprogesterone Acetate Injectable Suspension 25 in 1 CARTON INJECTION, SUSPENSION 25 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 24201-150 MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [HIKMA PHARMACEUTICALS USA INC.] 3 Current NDC, 3 package rows 20250110_0476eac5-d96c-4910-aa86-1ddeeefefe50.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 24201-150-00 24201015000 1 mL in 1 VIAL 1 ml Historical 24201-150-01 24201015001 1 VIAL in 1 CARTON (24201-150-01) / 1 mL in 1 VIAL (24201-150-00) 1 vial 2023-05-01 No No Current 24201-150-25 24201015025 25 VIAL in 1 CARTON (24201-150-25) / 1 mL in 1 VIAL (24201-150-00) 25 vial 2023-05-01 No No Current